Indeed, β-TrCP1 is overexpressed in various types of cancer including colorectal cancer [111], pancreatic cancer [112], melanoma [113], and hepatoblastoma [114] in a manner independent of β-catenin mutational status. Here, BTRC is linked to cancer.